School of Medicine Faculty Member Awarded Bayer Research Contract
Dr. Richard Sabina in the Oakland University William Beaumont School of Medicine has been awarded a contract from Bayer CropScience that will support a collaborative project to develop herbicides that inhibit an essential enzyme for plant life, AMP deaminase. Notably, reduced AMP deaminase activity may result in protection of cardiac function in patients with heart disease, thus these inhibitors may also have therapeutic applications. Collaborators on this project include structural biologists and chemists at Bayer and Dr. Arik Dvir, Chairman of the Department of Biological Sciences at Oakland University.
Created by Christina Grabowski (grabowsk@oakland.edu) on Tuesday, February 16, 2010 Modified by Christina Grabowski (grabowsk@oakland.edu) on Tuesday, February 16, 2010 Article Start Date: Tuesday, February 16, 2010
